CRBU vs NWSA · rev $3.9M vs rev $9.03B
Caribou Biosciences Inc (CRBU) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
CRBU currently screens at market cap $190.4M. NWSA currently screens at market cap $0.
Not investment advice. Open the CRBU and NWSA stock pages for the full models.
Not investment advice.